Telemedicine and Increasing Access to MOUD Care in Rural Communities

Course Description

The Greater Southern California Node (GSCN) of the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN), in partnership with the Pacific Southwest Addiction Technology Transfer Center (PSATTC), presents a 4-part training series addressing the implementation and sustainability of medications for opioid use disorders (MOUD) in rural settings. The series is hosted by Larissa Mooney, M.D., who is a Professor of Clinical Psychiatry and the Director of the Addiction Psychiatry Division in the Department of Psychiatry and Biomedical Sciences at UCLA. She is also a Principal Investigator for the GSCN of the NIDA CTN.

This on-demand course is the second session in a 4-part series that addresses the strengths and challenges to providing MOUD in rural communities. This session discussed the role that telemedicine can play in expanding access to MOUD in such areas. Telemedicine can be provided by rural clinics themselves, or by external telemedicine providers to whom a rural clinic refers some or all of its patients with OUD. Through case examples, the presenters highlighted how telemedicine has been used to improve access to initiating and maintaining MOUD in rural communities, and shared experiences using telemedicine approaches.

Please note, individuals can earn free CMEs and CEs for their attendance and sessions do not build on one another; individuals are free to select which topics are most relevant to them.

Launch Date: May 5, 2023

At the conclusion of the on-demand course, participants will be able to:

1. Recognize two (2) key barriers to the successful implementation of medication for opioid use disorder (MOUD) in rural clinics.
2. Explain two (2) approaches of telehealth and hybrid options for providing MOUD in clinical settings.
3. Identify (2) characteristics of patients who are more likely to be retained in care with telemedicine options.

Instructions for Continuing Education Credits

How to receive a CE/CME certificate:

For Continuing Medical Education (CME) for physicians, physician assistants, nurses, and nurse practitioners only, you will receive a link to complete the course evaluation for CME after watching the video for this course, and you will receive your CE certificate via email within six to eight weeks.

If you have any UCLA ISAP CME-related questions, please contact Gloria Miele at gmiele@mednet.ucla.edu.

CME Statements:

Please view the linked CME Learner Handout for more information about how to obtain CME credit.

The training course meets the qualifications for the provision of one (1) continuing medical education credit/contact hour (CME/CEH).

UCLA Integrated Substance Abuse Programs (ISAP) is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

UCLA Integrated Substance Abuse Programs (ISAP) designates this learning course for a maximum of one (1) AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 Credits^TM (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.

Continuing medical education will be awarded within 6-8 weeks following completion of the training.

Continuing Education: 

UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for one hour of continuing education credit for LMFTs, LCSWs, LPCCs, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-21-339-1225), CATCs (ACCBC/ CAADE, #CP40 872 C 0825), and CAODCs (CADTP, #151).

CE credit will be awarded at the conclusion of the training. Upon completing the final module, you must pass the final test with a minimum of 80% correct. Once you pass the final test, it will display a link to complete a course evaluation and submit the required information for your CE certificate. Upon completing this required course evaluation, you will receive your CE certificate via email within six to eight weeks.

If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.

Estimated time to complete the course:

This course should take approximately one (1) hour to complete.

Cost:

Free

Disclosure statements:

Lewei “Allison” Lin, MD, MS, Assistant Professor & Addiction Psychiatrist, Department of Psychiatry, University of Michigan

Kelly Peck, MD, Research Assistant Professor, University of Vermont College of Medicine, Department of Psychiatry, University of Vermont Department of Psychological Science

Greg Greenburg, MD, Medical Director, New Life Health Authority

Joan Kandel, DO, FAAFP, FASAM, Physician, Bright Heart Health

Moderated by Andrew Saxon, MD, Physician, Clinical Immunology and Allergy, University of California, Los Angeles

None of the presenters, planners, or others in control of content for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Presenters:

Lewei “Allison” Lin, MD, MS, Assistant Professor & Addiction Psychiatrist, Department of Psychiatry, University of Michigan

Kelly Peck, MD, Research Assistant Professor, University of Vermont College of Medicine, Department of Psychiatry, University of Vermont Department of Psychological Science

Greg Greenburg, MD, Medical Director, New Life Health Authority

Joan Kandel, DO, FAAFP, FASAM, Physician, Bright Heart Health

Moderated by Andrew Saxon, MD, Physician, Clinical Immunology and Allergy, University of California, Los Angeles

Recommended Audience:

This online course is recommended for primary clinicians and community health providers who are involved in providing multidisciplinary care to persons with opioid, stimulant, and other substance use disorders, including, but not limited to:

• Physicians
• Physician Assistants
• Nurse Practitioners
• Registered Nurses and LVNs
• Psychologists
• Marriage and Family Therapists
• Social Workers
• Alcohol and Other Drug and Mental Health Counselors
• Case Managers
• Medical Assistants

Instructions for Requesting Accommodations for Disability:

If you need a disability-related reasonable accommodation/alternative format for this event, please contact Darren Manley at dmanley@mednet.ucla.edu.

Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:

Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing: (UCLA ISAP, 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck).

Please click on the lesson below to start the course.